Atypical metastases from prostate cancer: 10-year experience at a single institution

American Journal of Roentgenology

Volumn 199, Issue 2, 2012, Pages 367-372

  Vinjamoori, Anant H ^a   Jagannathan, Jyothi P ^a   Shinagare, Atul B ^a   Taplin, Mary Ellen ^a   Oh, William K ^a   Van Den Abbeele, Annick D ^a   Ramaiya, Nikhil H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Atypical metastatic sites; Oncologic imaging; Osseous metastases; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADRENAL METASTASIS; ADULT; AGED; ARTICLE; BONE METASTASIS; CONTROLLED STUDY; GLEASON SCORE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PLEURA METASTASIS; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RETROSPECTIVE STUDY; SUPRADIAPHRAGMATIC LYMPH NODE; VISCERAL METASTASIS;

AGED; AGED, 80 AND OVER; BIOPSY; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84864757117     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.7533     Document Type: Article

References (26)

1. American Cancer Society. Cancer facts & figures 2001. New York, NY: American Cancer Society, 2001
2. Spencer JA, Golding SJ. Patterns of lymphatic metastases at recurrence of prostate cancer: CT findings. Clin Radiol 1994; 49:404-407 (Pubitemid 24179284)
3. Hayward SJ, McIvor J, Burdge AH, Jewkes RF, Williams G. Staging of prostatic carcinoma with radionuclide bone scintography and lymphography. Br J Radiol 1987; 60:79-81 (Pubitemid 17019653)
4. Long MA, Husband JE. Features of unusual metastases from prostate cancer. Br J Radiol 1999; 72:933-941 (Pubitemid 29484354)
5. Coakley FV, Lin RY, Schwartz LH, Panicek DM. Mesenteric adenopathy in patients with prostate cancer: frequency and etiology. AJR 2002; 178:125-127 (Pubitemid 34016386)
6. Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000; 85:60-67
7. McDavid K, Lee J, Fulton JP, Tonita J, Thompson TD. Prostate cancer incidence and mortality rates and trends in the United States and Canada. Public Health Rep 2004; 119:174-186 (Pubitemid 38661087)
8. Quinn M, Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I. International comparisons. BJU Int 2002; 90:162-173 (Pubitemid 34779587)
9. Collin SM, Martin RM, Metcalfe C, et al. Prostate- cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol 2008; 9:445-452
10. Mettlin CJ, Murphy GP, McDonald CJ, Menck HR. The National Cancer Database Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer 1999; 86:1877-1882 (Pubitemid 29513059)
11. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999; 17:1499-1507 (Pubitemid 29220858)
12. Akin O, Hricak H. Imaging of prostate cancer. Radiol Clin North Am 2007; 45:207-222 (Pubitemid 44854046)
13. Abouelfadel Z, Miller GJ, Glode LM, et al. High Gleason scores and lower prostate-specific antigen levels in a single institution over the past decade. Clin Prostate Cancer 2002; 1:115-117 (Pubitemid 37012408)
14. Bubendorf L, Schöpfer A, Wagner U, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 2000; 31:578-583 (Pubitemid 30323983)
15. Tan W, Buskirk S. Histologically diagnosed lung metastasis from prostate cancer: diagnosis, clinical course and response to treatment (abstr). ASCO 2005: American Society of Clinical Onclogy. Alexandria, VA: ASCO, 2005: abstract no. 309
16. Batson OV. The function of the vertebral veins and their role in the spread of metastases. Ann Surg 1940; 112:138-149
17. Morgan-Parkes JH. Metastases: mechanisms, pathways, and cascades. AJR 1995; 164:1075-1082
18. Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA 2003; 289:1414-1420 (Pubitemid 37430309)
19. Moul JW. Population screening for prostate cancer and emerging concepts for young men. Clin Prostate Cancer 2003; 2:87-97 (Pubitemid 37296102)
20. Schröder FH, Hugosson J, Roobol MJ, et al.; ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360:1320-1328
21. Andriole GL, Crawford ED, Grubb RL 3rd, et al.; PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009; 360:1310-1319 [Erratum in N Engl J Med 2009; 360:1797]
22. Bibikova M, Chudin E, Arsanjani A, et al. Expression signatures that correlated with Gleason score and relapse in prostate cancer. Genomics 2007; 89:666-672 (Pubitemid 46729630)
23. Furusato B, Shaheduzzaman S, Petrovics G, et al. Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens. Prostate Cancer Prostatic Dis 2008; 11:194-197 (Pubitemid 351676610)
24. Golias Ch, Charalabopoulos A, Stagikas D, et al. Molecular profiling and genomic microarrays in prostate cancer. Exp Oncol 2007; 29:82-84 (Pubitemid 47310499)
25. Foye A, Febbo PG. Cancer gene profiling in prostate cancer. Methods Mol Biol 2010; 576:293-326
26. Qian DZ, Huang CY, O'Brien CA, et al. Prostate cancer-associated gene expression alterations determined from needle biopsies. Clin Cancer Res 2009; 15:3135-3142